BRANDT ERIC sold $19.1M of LRCX
BRANDT ERIC sold 54,500 shares of LAM RESEARCH CORP (LRCX) at an average of $350.80 ($337.56–$364.00, $19.12M total) across 26 trades on 2026-06-11 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
A director sold ~$19.1M of LRCX shares across 26 trades at $337.56–$364.00, executed 2026-06-11, under a pre-arranged 10b5-1 plan; this can slightly pressure sentiment but is not a fundamental catalyst.
Market read
Primary-source insider selling disclosure; likely modest sentiment impact only.
What to watch
Traders may overreact to insider sales; without accompanying buys, guidance changes, or operational news, the signal is usually secondary.
Background
The article is an SEC Form 4 insider transaction disclosure for LAM Research (LRCX).
Ticker impact
LRCX discloses a director’s open-market sale of 54,500 shares (~$19.1M) under a pre-arranged 10b5-1 plan on 2026-06-11.
Likely limited near-term impact; any effect should be small and fade unless paired with other catalysts.
The filing is primary-source (Form 4) and sizable in dollars, but it is explicitly under a pre-arranged 10b5-1 plan, which typically dampens market reaction.
Market effects
No direct sector read-through; this is company-specific insider activity in semicap equipment.
None indicated.
None indicated.
Counterpoint
Because the sale is under a pre-arranged 10b5-1 plan, it may reflect routine liquidity needs rather than a bearish view on LRCX fundamentals.
Key entities
- issuerLAM Research Corp
Subject of the Form 4 insider transaction disclosure.
- insiderBRANDT ERIC
Director who sold 54,500 shares of LRCX under a 10b5-1 plan.
